GLPG Galapagos Announces Topline Results From Phase 3 Diversity Trial Of Filgotinib In Crohn's Disease$Galapagos(GLPG)$
| 发布于: 修改于: | Android | 转发：1 | 回复：2 | 喜欢：0 |
GLPG Galapagos Announces Topline Results From Phase 3 Diversity Trial Of Filgotinib In Crohn's Disease$Galapagos(GLPG)$
Filgotinib的克罗恩病三期临床失败了。不光是加拉帕戈斯损失惨重，吉利德同样会闷闷不乐。